Company

Eli Lilly and Company

Description

Company

1 connections

PeersCompetition and partners

Relationship began2026

Eli Lilly and CompanyCompany · 1 connections

Layer 1

Arrows show the direction of the relationship. Filter to focus on a business area.

Showing 1 to 1 of 1

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

Mediar is conducting the Phase 2 WISPer study under a global licensing agreement with Eli Lilly and Company.

PR Newswire news releases · 2026-10-07 19:08

View evidence

CompanyPR Newswire news releases2026-10-07 19:08
Mediar is conducting the Phase 2 WISPer study under a global licensing agreement with Eli Lilly and Company.
View source

Showing 1 to 1 of 1

Valuation data is available on Pro and Research.

Not available: Company signals · Financials · Filings · Guidance